Compounds and compositions as c-kit and PDGFR kinase inhibitors

Details for Australian Patent Application No. 2008247442 (hide)

Owner Novartis AG IRM LLC

Inventors Li, Xiaolin; Molteni, Valentina; Ramsey, Timothy; Liu, Xiaodong; Nabakka, Juliet; Chianelli, Donatella; Loren, Jon; Breitenstein, Werner

Agent Davies Collison Cave

Pub. Number AU-A-2008247442

PCT Pub. Number WO2008/137794

Priority 60/916,051 04.05.07 US

Filing date 2 May 2008

Wipo publication date 13 November 2008

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

3 December 2009 PCT application entered the National Phase

  PCT publication WO2008/137794 Priority application(s): WO2008/137794

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008247445-Water soluble magnesium compounds as cleaning agents and methods of using them

2008247441-Unit dose formulations and methods of treating and preventing thrombosis with thromboxane receptor antagonists